{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:29:53Z","timestamp":1791815393245,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K19589"],"award-info":[{"award-number":["25K19589"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25HP8021"],"award-info":[{"award-number":["25HP8021"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-66974-4","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:03:34Z","timestamp":1764842614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Autoantibody landscape and functional role of anti-C-C motif chemokine receptor 8 autoantibodies in systemic sclerosis: post-hoc analysis of a B-cell depletion trial"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6755-8047","authenticated-orcid":false,"given":"Kazuki M.","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8488-635X","authenticated-orcid":false,"given":"Yang-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ebata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5000-5203","authenticated-orcid":false,"given":"Kazuhiro","family":"Iwadoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2261-7469","authenticated-orcid":false,"given":"Ai","family":"Kuzumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Yoshizaki-Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Che E.","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9237-2260","authenticated-orcid":false,"given":"Hsin-Su","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0531-559X","authenticated-orcid":false,"given":"Hayakazu","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"66974_CR1","first-page":"1","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore, Y. et al. Systemic sclerosis. Nat. Rev. Dis. Prim. 1, 1\u201321 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"66974_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","volume":"44","author":"M Rubio-Rivas","year":"2014","unstructured":"Rubio-Rivas, M., Royo, C., Sime\u00f3n, C. P., Corbella, X. & Fonollosa, V. Mortality and survival in systemic sclerosis: Systematic review and meta-analysis. Semin. Arthritis Rheum. 44, 208\u2013219 (2014).","journal-title":"Semin. Arthritis Rheum."},{"key":"66974_CR3","doi-asserted-by":"crossref","unstructured":"Matsuda, K. M. et al. Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study. Arthritis Res. Ther. 21, 129 (2019).","DOI":"10.1186\/s13075-019-1919-6"},{"key":"66974_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.2353\/ajpath.2006.060205","volume":"169","author":"M Hasegawa","year":"2006","unstructured":"Hasegawa, M. et al. B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Am. J. Pathol. 169, 954\u2013966 (2006).","journal-title":"Am. J. Pathol."},{"key":"66974_CR5","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1002\/art.41798","volume":"73","author":"H Numajiri","year":"2021","unstructured":"Numajiri, H. et al. B Cell depletion inhibits fibrosis via suppression of profibrotic macrophage differentiation in a mouse model of systemic sclerosis. Arthritis Rheumatol. 73, 2086\u20132095 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"66974_CR6","doi-asserted-by":"publisher","unstructured":"Fukasawa, T. et al. Single-cell-level protein analysis revealing the roles of autoantigen-reactive B lymphocytes in autoimmune disease and the murine model. https:\/\/doi.org\/10.7554\/eLife.","DOI":"10.7554\/eLife"},{"key":"66974_CR7","doi-asserted-by":"crossref","unstructured":"Frantz, C., Auffray, C., Avouac, J. & Allanore, Y. Regulatory T cells in systemic sclerosis. Front. Immunol. 9, 2356 (2018).","DOI":"10.3389\/fimmu.2018.02356"},{"key":"66974_CR8","doi-asserted-by":"crossref","unstructured":"Kobayashi, S., Nagafuchi, Y., Shoda, H. & Fujio, K. The pathophysiological roles of regulatory T cells in the early phase of systemic sclerosis. Front. Immunol. 13, 900638 (2022).","DOI":"10.3389\/fimmu.2022.900638"},{"key":"66974_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85895-2","volume":"15","author":"A Sekiguchi","year":"2025","unstructured":"Sekiguchi, A. et al. Inhibition of skin fibrosis via regulation of Th17\/Treg imbalance in systemic sclerosis. Sci. Rep. 15, 1423 (2025).","journal-title":"Sci. Rep."},{"key":"66974_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9092687","volume":"9","author":"Y Asano","year":"2020","unstructured":"Asano, Y. The pathogenesis of systemic sclerosis: An understanding based on a common pathologic cascade across multiple organs and additional organ-specific pathologies. J. Clin. Med. 9, 1\u201327 (2020).","journal-title":"J. Clin. Med."},{"key":"66974_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.semarthrit.2016.10.003","volume":"46","author":"D Daoussis","year":"2017","unstructured":"Daoussis, D. et al. A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease. Semin. Arthritis Rheum. 46, 625\u2013631 (2017).","journal-title":"Semin. Arthritis Rheum."},{"key":"66974_CR12","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1093\/rheumatology\/key213","volume":"57","author":"G Sircar","year":"2018","unstructured":"Sircar, G., Goswami, R. P., Sircar, D., Ghosh, A. & Ghosh, P. Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: Open label, randomized, controlled trial. Rheumatol. (U. Kingd.) 57, 2106\u20132113 (2018).","journal-title":"Rheumatol. (U. Kingd.)"},{"key":"66974_CR13","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/1346-8138.15079","volume":"46","author":"S Ebata","year":"2019","unstructured":"Ebata, S. et al. Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease. J. Dermatol. 46, 1006\u20131013 (2019).","journal-title":"J. Dermatol."},{"key":"66974_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-020-02153-8","volume":"22","author":"J Einhaus","year":"2020","unstructured":"Einhaus, J. et al. Inhibition of effector B cells by ibrutinib in systemic sclerosis. Arthritis Res. Ther. 22, 1\u20138 (2020).","journal-title":"Arthritis Res. Ther."},{"key":"66974_CR15","doi-asserted-by":"crossref","unstructured":"Matsuda, K. M. et al. An open-label randomized parallel-group phase I study of the oral Bruton tyrosine kinase inhibitor tirabrutinib in systemic sclerosis. Br. J. Dermatol. in press, (2025).","DOI":"10.1093\/bjd\/ljaf168"},{"key":"66974_CR16","doi-asserted-by":"publisher","unstructured":"Ando, T. & Oda, H. Bruton tyrosine kinase inhibition in systemic sclerosis: a promising new B-cell therapy. Br. J. Dermatol. ljaf202 https:\/\/doi.org\/10.1093\/bjd\/ljaf202 (2025).","DOI":"10.1093\/bjd\/ljaf202"},{"key":"66974_CR17","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1136\/ard-2023-223952","volume":"82","author":"C Bergmann","year":"2023","unstructured":"Bergmann, C. et al. Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells. Ann. Rheum. Dis. 82, 1117\u20131120 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"66974_CR18","doi-asserted-by":"publisher","first-page":"543 LP","DOI":"10.1136\/ard-2023-225174","volume":"83","author":"W Merkt","year":"2024","unstructured":"Merkt, W. et al. Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis. Ann. Rheum. Dis. 83, 543 LP\u2013543546 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"66974_CR19","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2308917","volume":"390","author":"M Fabian","year":"2024","unstructured":"Fabian, M. et al. CD19 CAR T-cell therapy in autoimmune disease \u2014 a case series with follow-up. N. Engl. J. Med. 390, 687\u2013700 (2024).","journal-title":"N. Engl. J. Med."},{"key":"66974_CR20","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1093\/rheumatology\/keac578","volume":"62","author":"LI Sakkas","year":"2023","unstructured":"Sakkas, L. I., Katsiari, C. G., Daoussis, D. & Bogdanos, D. P. The role of B cells in the pathogenesis of systemic sclerosis: an update. Rheumatology 62, 1780\u20131786 (2023).","journal-title":"Rheumatology"},{"key":"66974_CR21","doi-asserted-by":"publisher","first-page":"AB27","DOI":"10.1016\/j.jaci.2024.12.089","volume":"155","author":"A Malasheuskaya","year":"2025","unstructured":"Malasheuskaya, A. et al. Regulatory T-cell immunotherapy as treatment of systemic sclerosis. J. Allergy Clin. Immunol. 155, AB27 (2025).","journal-title":"J. Allergy Clin. Immunol."},{"key":"66974_CR22","doi-asserted-by":"publisher","first-page":"e546","DOI":"10.1016\/S2665-9913(22)00131-X","volume":"4","author":"S Ebata","year":"2022","unstructured":"Ebata, S. et al. Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial. Lancet Rheumatol. 4, e546\u2013e555 (2022).","journal-title":"Lancet Rheumatol."},{"key":"66974_CR23","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/jamadermatol.2022.6340","volume":"159","author":"A Kuzumi","year":"2023","unstructured":"Kuzumi, A. et al. Long-term outcomes after rituximab treatment for patients with systemic sclerosis: follow-up of the DESIRES Trial With a Focus on Serum Immunoglobulin Levels. JAMA Dermatol. 159, 374\u2013383 (2023).","journal-title":"JAMA Dermatol."},{"key":"66974_CR24","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1093\/rheumatology\/keac023","volume":"61","author":"S Ebata","year":"2022","unstructured":"Ebata, S. et al. Predictors of rituximab effect on modified Rodnan skin score in systemic sclerosis: a machine-learning analysis of the DesiReS trial. Rheumatology 61, 4364\u20134373 (2022).","journal-title":"Rheumatology"},{"key":"66974_CR25","doi-asserted-by":"publisher","unstructured":"Kuzumi, A. et al. Predictors of rituximab efficacy in systemic sclerosis-associated interstitial lung disease: machine-learning analysis of the DESIRES trial. Rheumatology keae716 https:\/\/doi.org\/10.1093\/rheumatology\/keae716 (2024).","DOI":"10.1093\/rheumatology\/keae716"},{"key":"66974_CR26","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1182\/blood-2007-12-129262","volume":"112","author":"R Stasi","year":"2008","unstructured":"Stasi, R. et al. Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell\u2013depleting therapy with rituximab. Blood 112, 1147\u20131150 (2008).","journal-title":"Blood"},{"key":"66974_CR27","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41390-018-0088-7","volume":"84","author":"D Bhatia","year":"2018","unstructured":"Bhatia, D. et al. Rituximab modulates T- and B-lymphocyte subsets and urinary CD80 excretion in patients with steroid-dependent nephrotic syndrome. Pediatr. Res. 84, 520\u2013526 (2018).","journal-title":"Pediatr. Res."},{"key":"66974_CR28","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0889-857X(05)70297-0","volume":"22","author":"Y Okano","year":"1996","unstructured":"Okano, Y. Antinuclear antibody in systemic sclerosis (scleroderma). Rheum. Dis. Clin. North Am. 22, 709\u2013735 (1996).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"66974_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nrrheum.2009.238","volume":"6","author":"SI Nihtyanova","year":"2010","unstructured":"Nihtyanova, S. I. & Denton, C. P. Autoantibodies as predictive tools in systemic sclerosis. Nat. Rev. Rheumatol. 6, 112\u2013116 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"66974_CR30","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/S2665-9913(21)00107-7","volume":"3","author":"S Ebata","year":"2021","unstructured":"Ebata, S. et al. Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial. Lancet Rheumatol. 3, e489\u2013e497 (2021).","journal-title":"Lancet Rheumatol."},{"key":"66974_CR31","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/nmeth.1273","volume":"5","author":"N Goshima","year":"2008","unstructured":"Goshima, N. et al. Human protein factory for converting the transcriptome into an in vitro-expressed proteome. Nat. Methods 5, 1011\u20131017 (2008).","journal-title":"Nat. Methods"},{"key":"66974_CR32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/gtc.12832","volume":"26","author":"E Fukuda","year":"2021","unstructured":"Fukuda, E. et al. Identification and characterization of the antigen recognized by the germ cell mAb TRA98 using a human comprehensive wet protein array. Genes Cells 26, 180\u2013189 (2021).","journal-title":"Genes Cells"},{"key":"66974_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.893086","volume":"13","author":"KM Matsuda","year":"2022","unstructured":"Matsuda, K. M. et al. Autoantibody landscape revealed by wet protein array: sum of autoantibody levels reflects disease status. Front. Immunol. 13, 1\u201314 (2022).","journal-title":"Front. Immunol."},{"key":"66974_CR34","doi-asserted-by":"crossref","unstructured":"Kuzumi, A. et al. Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array. Front. Immunol. 14, 10.3389\/fimmu.2023.1255540 (2023).","DOI":"10.3389\/fimmu.2023.1255540"},{"key":"66974_CR35","doi-asserted-by":"publisher","first-page":"102995","DOI":"10.1016\/j.jaut.2023.102995","volume":"135","author":"KM Matsuda","year":"2023","unstructured":"Matsuda, K. M., Kotani, H., Yamaguchi, K., Okumura, T. & Fukuda, E. Significance of anti-transcobalamin receptor antibodies in cutaneous arteritis revealed by proteome-wide autoantibody screening. J. Autoimmun. 135, 102995 (2023).","journal-title":"J. Autoimmun."},{"key":"66974_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae063","author":"KM Matsuda","year":"2024","unstructured":"Matsuda, K. M. et al. Autoantibodies to nuclear valosin-containing protein-like protein: systemic sclerosis-specific antibodies revealed by in vitro human proteome. Rheumatol. (Oxf.) https:\/\/doi.org\/10.1093\/rheumatology\/keae063 (2024).","journal-title":"Rheumatol. (Oxf.)"},{"key":"66974_CR37","doi-asserted-by":"crossref","unstructured":"Matsuda, K. M. et al. Artificial intelligence and omics-based autoantibody profiling in dementia. Front Immunol. 16, 1537659 (2025).","DOI":"10.3389\/fimmu.2025.1537659"},{"key":"66974_CR38","doi-asserted-by":"crossref","unstructured":"Kotani, H. et al. Diversity and Epitope Spreading of Anti\u2013RNA Polymerase III Antibodies in Systemic Sclerosis: A Potential Biomarker for Skin and Lung Involvement. Arthritis Rheumatol. 77, 67\u201379 (2024).","DOI":"10.1002\/art.42975"},{"key":"66974_CR39","doi-asserted-by":"crossref","unstructured":"Matsuda, K. M. et al. Proteome-wide autoantibody screening and holistic autoantigenomic analysis unveil COVID-19 signature of autoantibody landscape. medRxiv 2024.06.07.24308592 (2024).","DOI":"10.1101\/2024.06.07.24308592"},{"key":"66974_CR40","doi-asserted-by":"crossref","unstructured":"Langfelder, P. & Horvath, S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).","DOI":"10.1186\/1471-2105-9-559"},{"key":"66974_CR41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1189\/jlb.0302105","volume":"73","author":"G Spinetti","year":"2003","unstructured":"Spinetti, G. et al. The chemokine receptor CCR8 mediates rescue from dexamethasone-induced apoptosis via an ERK-dependent pathway. J. Leukoc. Biol. 73, 201\u2013207 (2003).","journal-title":"J. Leukoc. Biol."},{"key":"66974_CR42","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.1073\/pnas.1621280114","volume":"114","author":"Y Barsheshet","year":"2017","unstructured":"Barsheshet, Y. et al. CCR8+FOXp3+ Treg cells as master drivers of immune regulation. Proc. Natl Acad. Sci. 114, 6086\u20136091 (2017).","journal-title":"Proc. Natl Acad. Sci."},{"key":"66974_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","volume":"13","author":"L Fagerberg","year":"2014","unstructured":"Fagerberg, L. et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol. Cell. Proteom. 13, 397\u2013406 (2014).","journal-title":"Mol. Cell. Proteom."},{"key":"66974_CR44","unstructured":"The Tabula Sapiens Consortium. The Tabula Sapiens: A multiple-organ, single-cell transcriptomic atlas of humans. Sci. (80-.) 376, eabl4896 (2022)."},{"key":"66974_CR45","doi-asserted-by":"crossref","unstructured":"Kuley, R. et al. N-Formyl Methionine Peptide-Mediated Neutrophil Activation in Systemic Sclerosis. Front Immunol. 12, 785275 (2022).","DOI":"10.3389\/fimmu.2021.785275"},{"key":"66974_CR46","doi-asserted-by":"crossref","unstructured":"Kondo, M. et al. Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis. Arthritis Res. Ther. 24, 210 (2022).","DOI":"10.1186\/s13075-022-02899-3"},{"key":"66974_CR47","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/art.42410","volume":"75","author":"S Klapa","year":"2023","unstructured":"Klapa, S. et al. Low Concentrations of C5a complement receptor antibodies are linked to disease activity and relapse in antineutrophil cytoplasmic autoantibody\u2013associated vasculitis. Arthritis Rheumatol. 75, 760\u2013767 (2023).","journal-title":"Arthritis Rheumatol."},{"key":"66974_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51125-9","volume":"9","author":"D Ernst","year":"2019","unstructured":"Ernst, D. et al. Lowered anti-beta1 adrenergic receptor antibody concentrations may have prognostic significance in acute coronary syndrome. Sci. Rep. 9, 14552 (2019).","journal-title":"Sci. Rep."},{"key":"66974_CR49","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1093\/eurheartj\/ehad666","volume":"44","author":"FS M\u00fcller","year":"2023","unstructured":"M\u00fcller, F. S. et al. Autoantibodies against the chemokine receptor 3 predict cardiovascular risk. Eur. Heart J. 44, 4935\u20134949 (2023).","journal-title":"Eur. Heart J."},{"key":"66974_CR50","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molimm.2020.12.027","volume":"131","author":"X Yue","year":"2021","unstructured":"Yue, X. et al. Autoantibodies against C5aR1, C3aR1, CXCR3, and CXCR4 are decreased in primary Sjogren\u2019s syndrome. Mol. Immunol. 131, 112\u2013120 (2021).","journal-title":"Mol. Immunol."},{"key":"66974_CR51","doi-asserted-by":"publisher","first-page":"e200099","DOI":"10.1212\/NXI.0000000000200099","volume":"10","author":"JM Schwab","year":"2025","unstructured":"Schwab, J. M. et al. Lesional antibody synthesis and complement deposition associate with de novo antineuronal antibody synthesis after spinal cord injury. Neurol. Neuroimmunol. Neuroinflammation 10, e200099 (2025).","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"66974_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i08","volume":"42","author":"D Ho","year":"2011","unstructured":"Ho, D., Imai, K., King, G. & Stuart, E. A. MatchIt: nonparametric preprocessing for parametric causal inference. J. Stat. Softw. 42, 1\u201328 (2011).","journal-title":"J. Stat. Softw."},{"key":"66974_CR53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5301\/jsrd.5000231","volume":"2","author":"D Khanna","year":"2017","unstructured":"Khanna, D. et al. Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J. Scleroderma Relat. Disord. 2, 11\u201318 (2017).","journal-title":"J. Scleroderma Relat. Disord."},{"key":"66974_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"66974_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"66974_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene Ontology: tool for the unification of biology. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"66974_CR57","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci."},{"key":"66974_CR58","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer, A., Green, J., Pollard, J. Jr & Tugendreich, S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523\u2013530 (2014).","journal-title":"Bioinformatics"},{"key":"66974_CR59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jdermsci.2023.01.007","volume":"109","author":"Y-Y Chen","year":"2023","unstructured":"Chen, Y.-Y. et al. Investigation of the keratinocyte transcriptome altered in high-glucose environment: An in-vitro model system for precision medicine. J. Dermatol. Sci. 109, 37\u201346 (2023).","journal-title":"J. Dermatol. Sci."},{"key":"66974_CR60","doi-asserted-by":"publisher","first-page":"123083","DOI":"10.1016\/j.lfs.2024.123083","volume":"357","author":"Y-Y Chen","year":"2024","unstructured":"Chen, Y.-Y., Huang, S.-M., Cheng, Y.-W., Hsu, Y.-L. & Lan, C.-C. E. High-glucose impact on UVB responses in human epidermal keratinocytes: Insights on diabetic skin\u2019s resistance to photocarcinogenesis. Life Sci. 357, 123083 (2024).","journal-title":"Life Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66974-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66974-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66974-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:03:45Z","timestamp":1764842625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66974-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["66974"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66974-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10872"}}